Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Coeptis Therapeutics Holdings (COEP) Cash & Current Investments (2021 - 2025)

Historic Cash & Current Investments for Coeptis Therapeutics Holdings (COEP) over the last 5 years, with Q3 2025 value amounting to $5.3 million.

  • Coeptis Therapeutics Holdings' Cash & Current Investments rose 36860.75% to $5.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $5.3 million, marking a year-over-year increase of 36860.75%. This contributed to the annual value of $532885.0 for FY2024, which is 6372.8% down from last year.
  • Per Coeptis Therapeutics Holdings' latest filing, its Cash & Current Investments stood at $5.3 million for Q3 2025, which was up 36860.75% from $3.0 million recorded in Q2 2025.
  • Over the past 5 years, Coeptis Therapeutics Holdings' Cash & Current Investments peaked at $7.4 million during Q3 2022, and registered a low of $532885.0 during Q4 2024.
  • Its 5-year average for Cash & Current Investments is $2.4 million, with a median of $2.1 million in 2023.
  • Per our database at Business Quant, Coeptis Therapeutics Holdings' Cash & Current Investments soared by 116077.32% in 2022 and then tumbled by 8085.03% in 2023.
  • Coeptis Therapeutics Holdings' Cash & Current Investments (Quarter) stood at $2.2 million in 2021, then surged by 73.95% to $3.8 million in 2022, then crashed by 61.25% to $1.5 million in 2023, then tumbled by 63.73% to $532885.0 in 2024, then surged by 900.25% to $5.3 million in 2025.
  • Its last three reported values are $5.3 million in Q3 2025, $3.0 million for Q2 2025, and $4.3 million during Q1 2025.